Draçini Xheladin, Çumashi Rudina, Qirjako Gentiana, Beaney Thomas, Kiru Gaia, Janssen-Telders Carolina, Fico Albana, Burazeri Genc
Faculty of Medicine, University of Medicine, Rr. 'Dibres', No. 371, Tirana 1000, Albania.
Department of Noncommunicable Diseases, Institute of Public Health, Tirana, Albania.
Eur Heart J Suppl. 2024 Jul 24;26(Suppl 3):iii5-iii7. doi: 10.1093/eurheartjsupp/suae045. eCollection 2024 Jun.
This article describes the May Measurement Month (MMM) 2021 campaign, which was the fourth time this annual hypertension screening campaign was conducted in Albania, a Mediterranean country in southeastern Europe. The MMM21 was conducted during the period of 28 September-30 November 2021, in 32 sites across several districts of Albania. Overall, 11 788 participants aged ≥18 years were included (63% women), with a mean age of 49.7 ± 14.9 years. Blood pressure (BP) was measured three times with Omron sphygmomanometers (model M3, Omron Healthcare, Kyoto, Japan), which are automatic upper arm BP monitors. Hypertension was defined as SBP ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg (based on the mean of the second and third recordings for SBP and DBP, respectively) or on antihypertensive medication. Self-reported data included pre-existing conditions, physical activity, smoking, alcohol consumption, COVID-19 testing, and use of contraception in women. Overall, 47.3% of screened participants had hypertension. Of those with hypertension, 70.1% were aware of their condition and 67.0% were on antihypertensive medication. About half (49.3%) of participants on antihypertensive medication had controlled BP (<140/90 mmHg). On average, BP was higher in those on antihypertensive medication and with increasing alcohol intake but lower in those with a history of stroke and those with higher levels of physical activity, previous positive COVID-19 test, and contraception use in women. In Albania, the MMM campaign continues to contribute to the early detection of hypertension among adults. Hence, it constitutes a valuable opportunistic screening instrument among other routine tools applied in the general Albanian population.
本文介绍了2021年5月测量月（MMM）活动，这是该年度高血压筛查活动第四次在阿尔巴尼亚开展，该国是欧洲东南部的一个地中海国家。2021年MMM活动于2021年9月28日至11月30日期间在阿尔巴尼亚多个地区的32个地点进行。总体而言，纳入了11788名年龄≥18岁的参与者（63%为女性），平均年龄为49.7±14.9岁。使用欧姆龙血压计（型号M3，欧姆龙医疗保健公司，日本京都）测量血压三次，该血压计为自动上臂血压监测仪。高血压定义为收缩压≥140 mmHg或舒张压（DBP）≥90 mmHg（分别基于收缩压和舒张压第二次和第三次测量值的平均值）或正在服用降压药。自我报告的数据包括既往疾病、身体活动、吸烟、饮酒、新冠病毒检测以及女性的避孕措施使用情况。总体而言，47.3%的筛查参与者患有高血压。在患有高血压的人群中，70.1%知晓自己的病情，67.0%正在服用降压药。服用降压药的参与者中约一半（49.3%）血压得到控制（<140/90 mmHg）。平均而言，服用降压药且饮酒量增加者的血压较高，但有中风病史者、身体活动水平较高者、既往新冠病毒检测呈阳性者以及女性使用避孕措施者的血压较低。在阿尔巴尼亚，MMM活动继续有助于早期发现成年人中的高血压。因此，在阿尔巴尼亚普通人群中应用的其他常规工具中，它是一种有价值的机会性筛查工具。
